TrialJournal of gastrointestinal cancer2019

Efficacy of Docetaxel and Oxaliplatin Regimen as a Second-Line Therapy for Patients with Advanced Pancreatic Adenocarcinoma.

Amal Rayan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.